Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AIDS Malignancy Consortium
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Atara Biotherapeutics
Rotkreuzklinikum München gGmbH
AIDS Malignancy Consortium
Universitätsklinikum Hamburg-Eppendorf
Zhejiang University
National Institutes of Health Clinical Center (CC)
Sanofi
Fondation Ophtalmologique Adolphe de Rothschild
National Institutes of Health Clinical Center (CC)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
AIDS Malignancy Consortium
Fred Hutchinson Cancer Center
Ontario Clinical Oncology Group (OCOG)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
French National Agency for Research on AIDS and Viral Hepatitis
NIH AIDS Clinical Trials Information Service